Table 2 Differential expression at specific chromosomal sites
From: Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas
Genes/ESTs | Locus | r | Reported frequency |
|---|---|---|---|
Gains | |||
S100A3 | 1q21 | 0.61 | 61%35 |
S100A8 | 1q21 | 0.69 | |
EST IMAGE 84820 | 6p21.1 | 0.67 | Reported but frequency not stated36 |
TUBB5 | 6p21.31 | 0.61 | |
ANLN | 7p14–15 | 0.60 | 44%35 |
EST IMAGE 771114 | 7p14.3 | 0.77 | |
ROM1 | 11q13 | 0.66 | 38%37 [11% High Level Amplification |
CD3G | 11q23 | 0.61 | at 11q23]35 |
TPD52L2 | 20q13.2 | 0.60 | 55% [11% High Level Amplification |
STK6 | 20q13.2 | 0.69 | at 20q13.2]35 |
Losses | |||
MRPS14 | 1q23–25 | −0.73 | |
EST IMAGE 814054 | 1q24–25 | −0.64 | |
TNC | 9q33 | −0.74 | 39% [9q33 commonly deleted]40 |
CCBL1 | 9q34.13 | −0.61 | |
DUSP5 | 10q25 | −0.65 | 30%35 |
EIF3S10 | 10q26 | −0.66 | |
EST IMAGE 591814 | 17p11.1 | −0.62 | 30%41 |
POLR2A | 17p13.1 | −0.65 | |
CGI-150 | 17p13.3 | −0.65 | |
VAMP2 | 17p31.1 | −0.62 | |
MADH4 | 18q21 | −0.64 | 58%35 |
ZNF24 | 18q12 | −0.62 | |
HPN | 19q11–13.2 | −0.67 | Reported but frequency not stated43 |
LENG4 | 19q13.3 | −0.63 |
